Biolegend, 141712, Alexa Fluor® 647 anti-mouse CD206 (MMR) Antibody, 100μg

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Recombinant mouse CD206 (MMR)
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 647 under optimal conditions.
Concentration: 0.5 mg/mL
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: ICFC - Quality tested FC, IHC-F - Verified
Recommended Usage: Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per million cells in 100 µL volume. For immunohistochemistry on frozen tissue sections, a concentration range of 2.5 - 5.0 µg/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 647 has a maximum emission of 668 nm when it is excited at 633 nm / 635 nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses
Excitation Laser: Red Laser (633 nm)
Application Notes: Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.
Application References(PubMed link indicates BioLegend citation): Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed Yang X, et al. 2015. PNAS. 112:2900. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed Barkaway A, et al. 2021. Immunity. . PubMed Chandran S, et al. 2020. Front Immunol. 11:787. PubMed Mizutani T, et al. 2023. iScience. 26:106081. PubMed Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed Graça FA, et al. 2023. Nat Commun. 14:2900. PubMed El-Naccache DW, et al. 2022. Cell Rep. 40:111150. PubMed Draijer C, et al. 2023. Front Immunol. 13:1056477. PubMed García-García A, et al. 2023. Bioact Mater. 24:174. PubMed Deville S, et al. 2022. Int J Mol Sci. 24: . PubMed Yang L, et al. 2023. Sci Rep. 13:1827. PubMed Chen K, et al. 2022. Adv Sci (Weinh). 9:e2104106. PubMed Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed Song Y, et al. 2013. Eur J Pharmacol. 705:49. PubMed Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed Tang E, et al. 2015. J Lipid Res. 56:358. PubMed Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed Helsley RN, et al. 2020. eLife. 8:e49882.. PubMed Chen L, et al. 2020. J Exp Med. 217:00:00. PubMed Calvo-Barreiro L, et al. 2021. Neurotherapeutics. . PubMed Brykczynska U, et al. 2020. Cell Reports. 30(5):1627-1643.e7.. PubMed Sato H, et al. 2020. Cell Reports. 31(5):107579. PubMed Howell KL, et al. 2021. FASEB J. 35:e21618. PubMed Xu Z, et al. 2022. Int J Mol Sci. 23:. PubMed Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed Enam SF, et al. 2020. J Neuroinflammation. 0.845138889. PubMed Kumaran Satyanarayanan S, et al. 2019. Nat Commun. 10:3471. PubMed Lee DY, et al. 2020. Chonnam Med J. 56:12:00. PubMed Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed Guo P, et al. 2021. J Immunol. 207:408. PubMed Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed De Simone G, et al. 2021. Immunity. :. PubMed Garre JM, et al. 2020. Nat Commun. 11:1784. PubMed Herrada AA, et al. 2022. Front Immunol. 13:841641. PubMed Blriot C, et al. 2021. Immunity. :. PubMed Ren Y, et al. 2020. Stem Cell Res Ther. 0.743055556. PubMed Wang H, et al. 2016. PLoS One. 11:e0167307. PubMed Li H, et al. 2022. Gut Microbes. 14:2127456. PubMed Carestia A, et al. 2019. Cell Rep. 28:896. PubMed Yu H, et al. 2021. Front Oncol. 11:736882. PubMed Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed He S, et al. 2021. Front Pharmacol. 12:743837. PubMed Zhu Q, et al. 2022. Atherosclerosis. 357:41. PubMed Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed Put S, et al. 2013. J Nucl Med. 54:807. PubMed Gao L, et al. 2021. Exp Ther Med. 22:1367. PubMed Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed Silva HM, et al. 2019. J Exp Med. 216:786. PubMed Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed Eixarch H, et al. 2020. Neurotherapeutics. 17:1988. PubMed Li H, et al. 2018. Nat Commun. 9:272. PubMed Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed Chakraborty A, et al. 2021. Biomaterials. 273:120796. PubMed
RRID: AB_10900240 (BioLegend Cat. No. 141711) AB_10900420 (BioLegend Cat. No. 141712)
Structure: Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution: Macrophages, dendritic cells, Langerhans cells, liver endothelial cells
Function: Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor: Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type: Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area: Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family: CD Molecules
Antigen References: 1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501. 2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469. 3. Burgdorf S, et al. 2006. J. Immunol. 176:6770. 4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.
Gene ID: 17533
UniProt: View information about CD206 on UniProt.org
Clone: C068C2
Regulatory Status: RUO
Other Names: MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype: Rat IgG2a, κ
Q: Why is mouse CD206 stained intracellularly and not via surface staining?
A: Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.